This brand name is authorized in Brazil
The drug TRINULOX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Tretinoin
UNII 5688UTC01R - TRETINOIN
|
|
Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones. |
|
2
Fluocinolone
UNII 0CD5FD6S2M - FLUOCINOLONE ACETONIDE
|
|
Fluocinolone acetonide is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
3
Hydroquinone
UNII XV74C1N1AE - HYDROQUINONE
|
|
Hydroquinone is a skin bleaching agent. Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3,4-dihydroxyphenylalanine (dopa). |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 507741501162419 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
